InsidersTradesSigma
Track the 信邦制药 share price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 信邦制药 has recorded 2 reports. Market capitalisation: €5.8bn. The latest transaction was reported on 23 May 2022 (Purchase). Among the most active insiders: 高文林. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
信邦制药是一家专注于健康和医药领域的公司，提供创新的医药产品。该公司在深圳证券交易所上市。